(Q44250284)

1 December 2017

Renal impairment is associated with coronary heart disease in HIV-positive men. (English)

1 reference

1 December 2017

coronary artery disease

1 reference

Lucy J Campbell

1

1 reference

1 December 2017

Mitesh Desai

2

1 reference

1 December 2017

Aseel Hegazi

3

1 reference

1 December 2017

Fowzia Ibrahim

4

1 reference

1 December 2017

Narbeh Melikian

5

1 reference

1 December 2017

Phillip Hay

6

1 reference

1 December 2017

Julie M Fox

7

1 reference

1 December 2017

Frank A Post

8

1 reference

1 December 2017

language of work or name

1 reference

1 November 2012

1 reference

1 December 2017

1 reference

1 December 2017

13

1 reference

1 December 2017

6

1 reference

1 December 2017

343-349

1 reference

Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy

1 December 2017

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Cardiovascular complications in HIV management: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Endothelial function in HIV-infected persons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Progression of carotid intima-media thickness in a contemporary human immunodeficiency virus cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Recent developments in HIV and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Reduced kidney function and preclinical atherosclerosis in HIV-infected individuals: the study of fat redistribution and metabolic change in HIV infection (FRAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Kidney function and the risk of cardiovascular events in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Development of diagnostic criteria for serious non-AIDS events in HIV clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Spectrum of chronic kidney disease in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Association of immunologic and virologic factors with myocardial infarction rates in a US healthcare system

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Abacavir use and risk of acute myocardial infarction and cerebrovascular events in the highly active antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Abacavir use and cardiovascular disease events: a meta-analysis of published and unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

Incipient Renal Impairment as a Predictor of Subclinical Atherosclerosis in HIV-Infected Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1310%2FHCT1306-343

21 January 2018

Identifiers

DOI

10.1310/HCT1306-343

1 reference

1 December 2017

1 reference